| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 02/11/2010 | US20100035954 Acid addition salts of muscarinic receptor antagonists |
| 02/11/2010 | US20100035869 Targeted nitroxide agents |
| 02/11/2010 | US20100035251 BioMarkers for the Progression of Alzheimer's Disease |
| 02/11/2010 | US20100034961 Photostabilized time temperature indicator |
| 02/11/2010 | US20100033088 Heterocyclic compound and organic electroluminescent device comprising the same |
| 02/11/2010 | US20100032656 Phenylcarbazole compounds, organic light emitting device comprising the phenylcarbazole compounds and flat panel display device comprising the organic light emitting device |
| 02/11/2010 | CA2733518A1 Treatment or prevention of hepatitis c with immunomodulator compounds |
| 02/11/2010 | CA2732883A1 C7-fluoro substituted tetracycline compounds |
| 02/11/2010 | CA2732091A1 Process for the preparation of a macrocycle |
| 02/10/2010 | EP2151428A1 Process for the preparation of agomelatin |
| 02/10/2010 | EP2150538A2 Novel 5-substituted hydantoins |
| 02/10/2010 | EP1701951B1 Modulators of peripheral 5-ht receptors |
| 02/10/2010 | EP1404659B1 4-aryl quinols and analogs thereof as therapeutic agents |
| 02/10/2010 | CN101646650A Sub-type selective azabicycloalkane derivatives |
| 02/10/2010 | CN101643445A Method for synthesizing N-R-carbazole single formylation derivatives |
| 02/10/2010 | CN101643444A Method and reaction device for preparing indole |
| 02/10/2010 | CN100588655C Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 02/10/2010 | CN100588398C Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances |
| 02/09/2010 | US7659415 Dianionic chelating ligands with a bridged-bis-bi-aryl structure; For catalytic polymerization of ethylene/olefin copolymers |
| 02/09/2010 | US7659304 Tryptophan derivative and application thereof |
| 02/09/2010 | US7659303 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders |
| 02/09/2010 | US7659302 Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione |
| 02/09/2010 | US7659300 2-(2-Oxo-3-pyridin-2-ylimidazolidin-1-yl)-N-(2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide; CGRP (Calcitonin Gene-Related Peptide); headache, migraine or cluster headache |
| 02/09/2010 | US7659297 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines |
| 02/09/2010 | US7659269 Substituted indolealkanoic acids |
| 02/09/2010 | CA2413061C Serine protease inhibitors |
| 02/09/2010 | CA2315646C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 02/09/2010 | CA2291065C Raf kinase inhibitors |
| 02/09/2010 | CA2274201C Di-or triaza-spiro[4,5]decane derivatives |
| 02/09/2010 | CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors |
| 02/04/2010 | WO2010014263A1 Methods and compositions involving (s)-bucindolol |
| 02/04/2010 | WO2010013168A1 3',6-substituted indirubins and their biological applications |
| 02/04/2010 | WO2010012747A1 New compounds |
| 02/04/2010 | WO2010012399A1 Indolylamides as modulators of the ep<sb>2</sb> receptor |
| 02/04/2010 | WO2010012397A1 N-(indol-3-ylalkyl)(hetero)arylamide derivatives as modulators of the ep2 receptor |
| 02/04/2010 | WO2010012396A1 5,6 substituted benzamide derivatives as modulators of the ep<sb>2 </sb>receptor |
| 02/04/2010 | WO2010012208A1 Process for the manufacture of agomelatine and its intermediate |
| 02/04/2010 | US20100029742 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 02/04/2010 | US20100029740 Azabicyclic compounds as serotonin, dopamine and norepinephrine re-uptake inhibitors |
| 02/04/2010 | US20100029738 Bicyclic Tetrahydropyrrole Compounds |
| 02/04/2010 | US20100029737 Inhibitors of d-amino acid oxidase |
| 02/04/2010 | US20100029700 1-(2-aryl-2-oxoethyl)-3-phenyl-1, 4-diazaspiro [4.5]dec-3-en-2-one derivatives and their use as glycine transporter inhibitors |
| 02/04/2010 | US20100029699 Matrix metalloproteinase inhibitors |
| 02/04/2010 | US20100029646 Prodrugs of diphenyl ox-indol-2-one compounds |
| 02/04/2010 | US20100029645 Inhibitors of Cytosolic Phospholipase A2 |
| 02/04/2010 | US20100029599 Indolylamides as modulators of the EP2 receptor |
| 02/04/2010 | US20100029598 Extended Benzamide Derivatives as Modulators of the EP2 Receptor |
| 02/04/2010 | US20100028329 Method for producing glycosylated indole compound and antibody against the compound |
| 02/04/2010 | US20100025669 Amine-based compound, organic light emitting device comprising the amine-based compound, and flat panel display device including the organic light emitting device |
| 02/04/2010 | US20100025661 Luminescent material and organic electroluminescent device using the same |
| 02/04/2010 | CA2732513A1 Methods and compositions involving (s)-bucindolol |
| 02/04/2010 | CA2732232A1 3',6-substituted indirubins and their biological applications |
| 02/04/2010 | CA2731919A1 New compounds |
| 02/03/2010 | EP2149555A1 Amine-based compound, organic light emitting device comprising the amine-based compound, and flat panel display device including the organic light emitting device |
| 02/03/2010 | EP2149554A1 Indolyamides as modulators for an EP2 receptor |
| 02/03/2010 | EP2149553A1 3', 6-substituted indirubins and their biological applications |
| 02/03/2010 | EP2149552A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors |
| 02/03/2010 | EP2149551A1 N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors |
| 02/03/2010 | EP2148860A1 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 02/03/2010 | EP2148858A1 Inhibitors of iap |
| 02/03/2010 | CN101641329A 6' substituted compounds having 5-ht6 receptor affinity |
| 02/03/2010 | CN101641328A Polymorphs of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide |
| 02/03/2010 | CN101638377A Amine-based compound, organic light emitting device and flat panel display device |
| 02/03/2010 | CN101638376A Method for preparing agomelatine and intermediate of agomelatine |
| 02/03/2010 | CN101638375A Method for effectively extracting indirubin from Chinese herbal medicine radix isatidis |
| 02/03/2010 | CN100586932C Antitumor compound and its preparation process |
| 02/03/2010 | CN100586931C Method for synthesizing 2,4-diamino[4'-(4-phenylacetylenylphthalimido)]diphenyl ether |
| 02/03/2010 | CN100586927C Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 02/02/2010 | US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 02/02/2010 | US7655691 Indole compounds useful as serotonin selective agents |
| 02/02/2010 | US7655690 1-sulfonylindole derivatives, their preparation and their use as 5-HT6 ligands |
| 02/02/2010 | US7655689 For treating cancer, cardiovascular, sexual and immune disorders; [3aS-(3a alpha ,4 beta ,5 beta ,7 beta ,7a alpha )]-4-(Octahydro-5-hydroxy-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2-(trifluoromethyl)benzonitrile (471 Di) |
| 02/02/2010 | US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 02/02/2010 | US7655661 Prodrugs of CC-1065 analogs |
| 02/02/2010 | US7655660 Antitumor antibiotic; water solubility, stability; N-[2-{(1-chloromethyl)-1,2-dihydro-5-[(4-methylpiperazino)carbonyloxy]-3H-benz(e)indol-3-yl}carbonyl]-1H-indol-5-yl]-5-[(3-methyldithio-1-oxopropyl)-amino]-1H-indole-2-carboxamide |
| 02/02/2010 | US7655641 3-(4-{2-[(5-Fluoro-3- methyl-benzo[b]thiophene-2- sulfonyl)-propyl- amino]-ethylsulfanyl}- 2-methyl-phenyl)- propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, hypertension, arteriosclerosis and cardiovascular diseases |
| 02/02/2010 | US7655217 Using water soluble dyes; fluorescence contrast agent |
| 02/02/2010 | CA2507923C Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| 02/02/2010 | CA2485685C Calcium receptor modulating agents |
| 02/02/2010 | CA2434162C Reaction method utilizing diaphram type catalyst and apparatus therefor |
| 02/02/2010 | CA2316172C Indole derivatives as inhibitors of factor xa |
| 01/28/2010 | WO2010011316A1 SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS |
| 01/28/2010 | WO2010011147A1 Indole compounds |
| 01/28/2010 | WO2010009508A1 Antiparasitic compounds |
| 01/28/2010 | WO2009118753A3 Process for preparation of naratriptan hydrochloride |
| 01/28/2010 | US20100023453 Dynamic number authentication for credit/debit cards |
| 01/28/2010 | US20100022613 Compounds Having CRTH2 Antagonist Activity |
| 01/28/2010 | US20100022550 Tetrahydrocarbazole derivatives useful as androgen receptor modulators |
| 01/28/2010 | US20100022514 Heterocycle Compounds and Methods of Use Thereof |
| 01/28/2010 | US20100019663 Fused aromatic compound and organic light emitting diode comprising organic layer comprising the same |
| 01/28/2010 | US20100019205 Liquid Fullerene Derivative, Method for Producing the Same, and Device Using the Same |
| 01/28/2010 | CA2730500A1 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid deri vatives useful in the treatment of autoimmune and inflammatory disorders |
| 01/27/2010 | EP2147433A2 Use of indolinium diazamethine cations for optical data recording |
| 01/27/2010 | EP2146958A1 Process for the preparation of form a of tegaserod |
| 01/27/2010 | EP1303503B1 Aniline derivatives |
| 01/27/2010 | CN101636385A Naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonists |
| 01/27/2010 | CN101636384A Inhibitors of D-amino acid oxidase |
| 01/27/2010 | CN101633637A 8-oxo-8H-acenaphtho[1,2-b]pyrrole derivative |
| 01/27/2010 | CN101633636A Peptidomimetic protease inhibitors |
| 01/27/2010 | CN101633635A Crystalline form of (2r,4r)-monatin potassium salt and sweetener composition containing same |